These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27344083)

  • 1. Aspirin, platelets, and cancer: The point of view of the internist.
    Santilli F; Boccatonda A; Davì G
    Eur J Intern Med; 2016 Oct; 34():11-20. PubMed ID: 27344083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents.
    Xu XR; Yousef GM; Ni H
    Blood; 2018 Apr; 131(16):1777-1789. PubMed ID: 29519806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin and antiplatelet treatments in cancer.
    Tao DL; Tassi Yunga S; Williams CD; McCarty OJT
    Blood; 2021 Jun; 137(23):3201-3211. PubMed ID: 33940597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of platelets in inflammation and cancer: novel therapeutic strategies.
    Dovizio M; Alberti S; Guillem-Llobat P; Patrignani P
    Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):118-27. PubMed ID: 24118902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unlocking Aspirin's Chemopreventive Activity: Role of Irreversibly Inhibiting Platelet Cyclooxygenase-1.
    Lichtenberger LM; Fang D; Bick RJ; Poindexter BJ; Phan T; Bergeron AL; Pradhan S; Dial EJ; Vijayan KV
    Cancer Prev Res (Phila); 2017 Feb; 10(2):142-152. PubMed ID: 27998883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carpe low-dose aspirin: the new anti-cancer face of an old anti-platelet drug.
    Mitrugno A; Sylman JL; Rigg RA; Tassi Yunga S; Shatzel JJ; Williams CD; McCarty OJT
    Platelets; 2018 Dec; 29(8):773-778. PubMed ID: 29265902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in platelet reactivity and response to low-dose aspirin therapy.
    Becker DM; Segal J; Vaidya D; Yanek LR; Herrera-Galeano JE; Bray PF; Moy TF; Becker LC; Faraday N
    JAMA; 2006 Mar; 295(12):1420-7. PubMed ID: 16551714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
    Larsen SB; Grove EL; Kristensen SD; Hvas AM
    Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin, platelet inhibition and cancer prevention.
    Patrignani P; Patrono C
    Platelets; 2018 Dec; 29(8):779-785. PubMed ID: 29985750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Panax notoginseng saponin is superior to aspirin in inhibiting platelet adhesion to injured endothelial cells through COX pathway in vitro.
    Wang MM; Xue M; Xu YG; Miao Y; Kou N; Yang L; Zhang Y; Shi DZ
    Thromb Res; 2016 May; 141():146-52. PubMed ID: 27043068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention.
    Ornelas A; Zacharias-Millward N; Menter DG; Davis JS; Lichtenberger L; Hawke D; Hawk E; Vilar E; Bhattacharya P; Millward S
    Cancer Metastasis Rev; 2017 Jun; 36(2):289-303. PubMed ID: 28762014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells.
    Guillem-Llobat P; Dovizio M; Bruno A; Ricciotti E; Cufino V; Sacco A; Grande R; Alberti S; Arena V; Cirillo M; Patrono C; FitzGerald GA; Steinhilber D; Sgambato A; Patrignani P
    Oncotarget; 2016 May; 7(22):32462-77. PubMed ID: 27074574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A brief review on high on-aspirin residual platelet reactivity.
    Pettersen AA; Arnesen H; Seljeflot I
    Vascul Pharmacol; 2015; 67-69():6-9. PubMed ID: 25869498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes.
    Schrottmaier WC; Kral JB; Badrnya S; Assinger A
    Thromb Haemost; 2015 Aug; 114(3):478-89. PubMed ID: 25904241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets and lipoprotein(a) in retinal vein occlusion: mutual targets for aspirin therapy.
    Lippi G; Franchini M; Targher G
    Thromb Haemost; 2007 Jun; 97(6):1059-60. PubMed ID: 17549315
    [No Abstract]   [Full Text] [Related]  

  • 17. Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost.
    Lessiani G; Vazzana N; Cuccurullo C; Di Michele D; Laurora G; Sgrò G; Di Ruscio P; Simeone E; Di Iorio P; Lattanzio S; Liani R; Ferrante E; Davì G
    Thromb Haemost; 2011 Feb; 105(2):321-8. PubMed ID: 21103664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 19. Laboratory effect on platelet activity within 24 h of the first 300-mg oral dose of aspirin given in hospital during the acute phase of ischemic cerebral events.
    Richard S; Toussaint-Hacquard M; Fay R; Lacour JC; Ducrocq X; Lecompte T
    Cerebrovasc Dis; 2012; 33(6):574-8. PubMed ID: 22710855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
    Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
    Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.